IL6 and myeloid sarcoma: However, our present study demonstrated that the release of IL-6 from BMECs is significantly higher in the acute phase NMO patients than in MS patients, healthy controls and even stable phase NMO patients, thus suggesting that BMECs, as well as astrocytes, may be a major source of IL-6 production during the acute phase of NMO.